CVE:ADK DIAGNOS (ADK) Stock Price, News & Analysis C$0.48 -0.01 (-1.04%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartInsider TradesNews and Trends About DIAGNOS Stock (CVE:ADK) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get DIAGNOS alerts:Sign Up Key Stats Today's RangeC$0.47▼C$0.4850-Day RangeC$0.23▼C$0.5052-Week RangeC$0.18▼C$0.52Volume61,732 shsAverage Volume226,309 shsMarket CapitalizationC$57.20 millionP/E RatioN/ADividend Yield0.29%Price TargetN/AConsensus RatingN/A Company Overview DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada. Read More Receive ADK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADK Stock News HeadlinesDIAGNOS (CVE:ADK) Director Robert Dunn Acquires 105,000 SharesAugust 29, 2026 | insidertrades.comDiagnos, Angkor, Aya at 52-Week Highs on NewsAugust 27, 2026 | ca.finance.yahoo.comAnthropic’s confidential SEC filing — and the public ticker that holds itAnthropic filed confidentially for an IPO, and its annualized revenue run rate reportedly surged to $65 billion in July - seven times last year's pace. One public ticker reportedly holds Anthropic alongside $190 billion Databricks and $61 billion Anduril - three private-company catalysts in a single brokerage trade. Alexander Green believes the next major catalyst could arrive as early as September 29, when The AI Conference begins in San Francisco.September 4 at 1:00 AM | The Oxford Club (Ad)Diagnos, Alkane, BCM at 52-Week Highs on NewsAugust 26, 2026 | ca.finance.yahoo.comDIAGNOS Inc.: DIAGNOS Announces Shares for Debt SettlementJune 19, 2026 | finanznachrichten.deDIAGNOS Inc.: DIAGNOS Provides an Update on Sales and Regulatory Activities for CARAApril 9, 2026 | finanznachrichten.deDiagnos Inc.January 21, 2026 | marketwatch.comDIAGNOS appoints new chief AI scientist to propel healthcare innovationDecember 16, 2025 | msn.comSee More Headlines ADK Stock Analysis - Frequently Asked Questions How have ADK shares performed this year? DIAGNOS's stock was trading at C$0.38 at the start of the year. Since then, ADK stock has increased by 26.7% and is now trading at C$0.48. How do I buy shares of DIAGNOS? Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of DIAGNOS own? Based on aggregate information from My MarketBeat watchlists, some other companies that DIAGNOS investors own include DIAGNOS (DGNOF), Facedrive (FDVRF), New Found Gold (NFGC), Ackroo (AKR), BeWhere (BEW), BlueRush (BTV) and Grande West Transportation Group (BUS). Industry, Sector and Symbol Stock ExchangeCVE SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolCVE:ADK CIKN/A Webwww.diagnos.ca Phone+1-450-6788882FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$3.81 million Net Margins-6,956.84% Pretax MarginN/A Return on Equity11,659.44% Return on Assets-134.33% Debt Debt-to-Equity Ratio204.05 Current Ratio1.49 Quick Ratio0.68 Sales & Book Value Annual SalesC$65.48 thousand Price / Sales873.52 Cash FlowC$0.01 per share Price / Cash Flow60.00 Book ValueC$0.01 per share Price / Book83.27Miscellaneous Outstanding Shares120,413,000Free FloatN/AMarket CapC$57.20 million OptionableNot Optionable Beta0.50 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (CVE:ADK) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...Behind the Markets | SponsoredRickards Predicts: Trump to buy tiny $2 stock?Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...Paradigm Press | SponsoredAnthropic’s confidential SEC filing — and the public ticker that holds itAnthropic filed confidentially for an IPO, and its annualized revenue run rate reportedly surged to $65 billio...The Oxford Club | SponsoredAfter KDA, PRE, and OCEAN—this is the one17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredNear retirement? Buy this stockOn August 9, the Wall Street Journal profiled a unique AI strategy used by three companies. Whitney Tilson of ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIAGNOS With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
